ПРЕЭКЛАМПИЯ, СВЯЗАННАЯ С ОЖИРЕНИЕМ: ИСХОДЫ ДЛЯ ПЛОДА И НОВОРОЖДЕННОГО (обзор литературы)
Аннотация
Статья посвящена изучению эпидемиологии факторов риска преэклампсии, в том числе отсроченного риска преэклампсии, связанного с ожирением. Ожирение – серьезный фактор риска преэклампсии. Во всем мире гипертонические расстройства при беременности и связанные с ними осложнения являются одной из основных причин заболеваемости и смертности матерей и их плодов/новорожденных. Исходы для плода и новорожденного, связанные с эклампсией и ее осложнениями, значительны, включая неонатальную смертность и серьезную отдаленную неонатальную заболеваемость.
Ключевые слова:
Об авторах
Список литературы
Dobrokhotova YuE, Dzhokhadze LS, Kuznetsov PA, Osmanova AP, Makarov OV. Preeclampsia: from history to the present day. Probl Reproduktsii 2015;21:120. https://doi.org/10.17116/repro2015215120-126.
WHO recommendations on drug treatment for non-severe hypertension in pregnancy n.d. https://www.who.int/publications/i/item/9789240008793 (accessed August 1, 2023).
Porreco RP, Barkey R. Peripartum intensive care. J Matern Fetal Neonatal Med 2010;23:1136–8. https://doi.org/10.3109/14767058.2010.490890.
Naderi S, Tsai SA, Khandelwal A. Hypertensive Disorders of Pregnancy. Curr Atheroscler Rep 2017;19:15. https://doi.org/10.1007/s11883-017-0648-z.
Slack E, Rankin J, Jones D, Heslehurst N. Effects of maternal anthropometrics on pregnancy outcomes in South Asian women: a systematic review. Obes Rev 2018;19:485–500. https://doi.org/10.1111/obr.12636.
Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet Lond Engl 2010;376:631–44. https://doi.org/10.1016/S0140-6736(10)60279-6.
Addabbo F, Nacci C, De Benedictis L, Leo V, Tarquinio M, Quon MJ, et al. Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-κB/COX-2 signaling in human aortic endothelial cells. Am J Physiol Endocrinol Metab 2011;301:E1143-1154. https://doi.org/10.1152/ajpendo.00208.2011.
Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 2011;342:d2901. https://doi.org/10.1136/bmj.d2901.
von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté A-M, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet Lond Engl 2011;377:219–27. https://doi.org/10.1016/S0140-6736(10)61351-7.
Wikström A-K, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertens Dallas Tex 1979 2010;55:1254–9. https://doi.org/10.1161/HYPERTENSIONAHA.109.147082.
Zhang L, Li X, Zhou C, You Z, Zhang J, Cao G. The diagnosis values of serum STAT4 and sEng in preeclampsia. J Clin Lab Anal 2020;34. https://doi.org/10.1002/jcla.23073.
Kharb S, Bala J, Nanda S. Markers of obesity and growth in preeclamptic and normotensive pregnant women. J Obstet Gynaecol J Inst Obstet Gynaecol 2017;37:610–5. https://doi.org/10.1080/01443615.2017.1286463.
Faupel-Badger JM, Staff AC, Thadhani R, Powe CE, Potischman N, Hoover RN, et al. Maternal angiogenic profile in pregnancies that remain normotensive. Eur J Obstet Gynecol Reprod Biol 2011;158:189–93. https://doi.org/10.1016/j.ejogrb.2011.05.001.
Robillard P-Y, Dekker G, Chaouat G, Hulsey TC, Saftlas A. Epidemiological studies on primipaternity and immunology in preeclampsia--a statement after twelve years of workshops. J Reprod Immunol 2011;89:104–17. https://doi.org/10.1016/j.jri.2011.02.003.
Liu N, Guo Y-N, Gong L-K, Wang B-S. Advances in biomarker development and potential application for preeclampsia based on pathogenesis. Eur J Obstet Gynecol Reprod Biol X 2021;9:100119. https://doi.org/10.1016/j.eurox.2020.100119.
Myers JE. What are the metabolic precursors which increase the risk of pre-eclampsia and how could these be investigated further. Placenta 2017;60:110–4. https://doi.org/10.1016/j.placenta.2017.08.011.
Hamilton D, Dee A, Perry IJ. The lifetime costs of overweight and obesity in childhood and adolescence: a systematic review. Obes Rev Off J Int Assoc Study Obes 2018;19:452–63. https://doi.org/10.1111/obr.12649.
Gibson C, Rohan AM, Gillespie KH. Severe Maternal Morbidity During Delivery Hospitalizations. WMJ Off Publ State Med Soc Wis 2017;116:215–20.
Shin D, Hur J, Cho E-H, Chung H-K, Shivappa N, Wirth MD, et al. Pre-Pregnancy Body Mass Index Is Associated with Dietary Inflammatory Index and C-Reactive Protein Concentrations during Pregnancy. Nutrients 2017;9:351. https://doi.org/10.3390/nu9040351.
Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol 2007;36:412–9. https://doi.org/10.1093/ije/dyl271.
Ankumah N-AE, Sibai BM. Chronic Hypertension in Pregnancy: Diagnosis, Management, and Outcomes. Clin Obstet Gynecol 2017;60:206–14. https://doi.org/10.1097/GRF.0000000000000255.
Caughey AB. Prepregnancy Obesity and Severe Maternal Morbidity: What Can Be Done? JAMA 2017;318:1765–6. https://doi.org/10.1001/jama.2017.16189.
Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens 2008;21:943–7. https://doi.org/10.1038/ajh.2008.219.
Chasan-Taber L, Silveira M, Waring ME, Pekow P, Braun B, Manson JE, et al. Gestational Weight Gain, Body Mass Index, and Risk of Hypertensive Disorders of Pregnancy in a Predominantly Puerto Rican Population. Matern Child Health J 2016;20:1804–13. https://doi.org/10.1007/s10995-016-1983-3.
Shaheen A, Nazli R, Fatima S, Ali R, Khan I, Khattak S. Adipokine Serum visfatin level in pregnancy induced hypertension and uncomplicated pregnancy. Pak J Med Sci 2016;32:1419–24. https://doi.org/10.12669/pjms.326.10917.
Subirana I, Fitó M, Diaz O, Vila J, Francés A, Delpon E, et al. Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism. Sci Rep 2018;8:3191. https://doi.org/10.1038/s41598-018-21482-y.
Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007;92:969–75. https://doi.org/10.1210/jc.2006-2083.
Sava RI, March KL, Pepine CJ. Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice. Clin Cardiol 2018;41:220–7. https://doi.org/10.1002/clc.22892.
Chen J-P, Chen G-C, Wang X-P, Qin L, Bai Y. Dietary Fiber and Metabolic Syndrome: A Meta-Analysis and Review of Related Mechanisms. Nutrients 2017;10:24. https://doi.org/10.3390/nu10010024.
Kazantseva VD, Ailarova IM, Me’lnikov AP. Markers of preeclampsia. Russian Bulletin of Obstetrician-Gynecologist 2022;4:31–8.
Tayal D, Goswami B, Patra SK, Tripathi R, Khaneja A. Association of inflammatory cytokines, lipid peroxidation end products and nitric oxide with the clinical severity and fetal outcome in preeclampsia in Indian women. Indian J Clin Biochem IJCB 2014;29:139–44. https://doi.org/10.1007/s12291-013-0320-5.
Как цитировать
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
